Targeted Grant Terminations Have Affected 694 NIH Grants

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 8, 2025 -- Targeted grant terminations have affected 694 National Institutes of Health (NIH) grants, resulting in $1.81 billion in terminated grant funding, according to a research letter published online May 8 in the Journal of the American Medical Association.

Michael Liu, M.Phil., from Harvard Medical School in Boston, and colleagues calculated the number and corresponding funding amounts of terminated NIH grants overall and by institute or center and award type. The proportions of terminated grants and funding dollars were calculated across all previously active grants.

The researchers found that 694 NIH grants were terminated across 24 of the 26 institutes and centers that administered active NIH grants between Feb. 28 and April 8, 2025. Of the grants administered by the NIH Clinical Center or the National Center for Complementary and Integrative Health, none were terminated. The cumulative amount of terminated grant funding was $1.81 billion; at the time of grant termination, 30.0 percent had not been expended. The highest number of grant terminations was seen at Columbia University (157 terminations), followed by Johns Hopkins University, Yale University, Emory University, and the University of Michigan (19, 14, 14, and 14 terminations, respectively). The largest number of terminated grants was administered by the National Institute of Mental Health and the National Institute on Minority Health and Health Disparities (128 and 77 terminations, respectively). Across the 694 terminated grants, 57.6, 20.0, 16.0, and 6.3 percent, respectively, were research project grants, early-career grants, other grants, and center grants, respectively.

"Ongoing monitoring and data transparency will be critical for understanding the impact of grant terminations on the U.S. health research enterprise," the authors write.

Two authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-05-09 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords